Bone Biologics (BBLG) Competitors $0.68 +0.01 (+1.45%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.68 -0.01 (-0.74%) As of 04/17/2025 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock BBLG vs. BSGM, NURO, INBS, DHAI, BLAC, BTCY, IINN, LYRA, MHUA, and TNONShould you be buying Bone Biologics stock or one of its competitors? The main competitors of Bone Biologics include BioSig Technologies (BSGM), NeuroMetrix (NURO), Intelligent Bio Solutions (INBS), DIH Holding US (DHAI), Bellevue Life Sciences Acquisition (BLAC), Biotricity (BTCY), Inspira Technologies Oxy B.H.N. (IINN), Lyra Therapeutics (LYRA), Meihua International Medical Technologies (MHUA), and Tenon Medical (TNON). These companies are all part of the "medical equipment" industry. Bone Biologics vs. BioSig Technologies NeuroMetrix Intelligent Bio Solutions DIH Holding US Bellevue Life Sciences Acquisition Biotricity Inspira Technologies Oxy B.H.N. Lyra Therapeutics Meihua International Medical Technologies Tenon Medical Bone Biologics (NASDAQ:BBLG) and BioSig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, community ranking, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends. Which has preferable valuation and earnings, BBLG or BSGM? Bone Biologics has higher earnings, but lower revenue than BioSig Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBone BiologicsN/AN/A-$8.95MN/AN/ABioSig Technologies$39K254.11-$29.04MN/AN/A Is BBLG or BSGM more profitable? Bone Biologics has a net margin of 0.00% compared to BioSig Technologies' net margin of -44,832.50%. BioSig Technologies' return on equity of 0.00% beat Bone Biologics' return on equity.Company Net Margins Return on Equity Return on Assets Bone BiologicsN/A -124.71% -111.64% BioSig Technologies -44,832.50%N/A -776.49% Does the media prefer BBLG or BSGM? In the previous week, BioSig Technologies had 1 more articles in the media than Bone Biologics. MarketBeat recorded 1 mentions for BioSig Technologies and 0 mentions for Bone Biologics. Bone Biologics' average media sentiment score of 0.00 equaled BioSig Technologies'average media sentiment score. Company Overall Sentiment Bone Biologics Neutral BioSig Technologies Neutral Which has more volatility and risk, BBLG or BSGM? Bone Biologics has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500. Comparatively, BioSig Technologies has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. Does the MarketBeat Community prefer BBLG or BSGM? BioSig Technologies received 103 more outperform votes than Bone Biologics when rated by MarketBeat users. CompanyUnderperformOutperformBone BiologicsN/AN/ABioSig TechnologiesOutperform Votes10370.55% Underperform Votes4329.45% Do analysts rate BBLG or BSGM? BioSig Technologies has a consensus target price of $2.75, suggesting a potential upside of 378.26%. Given BioSig Technologies' stronger consensus rating and higher probable upside, analysts clearly believe BioSig Technologies is more favorable than Bone Biologics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bone Biologics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00BioSig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of BBLG or BSGM? 34.3% of Bone Biologics shares are owned by institutional investors. Comparatively, 7.2% of BioSig Technologies shares are owned by institutional investors. 7.5% of Bone Biologics shares are owned by insiders. Comparatively, 17.0% of BioSig Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryBioSig Technologies beats Bone Biologics on 9 of the 13 factors compared between the two stocks. Get Bone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBLG vs. The Competition Export to ExcelMetricBone BiologicsSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.22M$8.59B$5.31B$7.35BDividend YieldN/A1.70%5.45%4.31%P/E RatioN/A18.6621.9417.82Price / SalesN/A70.67380.9497.68Price / CashN/A19.6738.2634.64Price / Book0.094.846.453.98Net Income-$8.95M$284.66M$3.22B$247.81M7 Day Performance-2.58%1.68%5.85%3.19%1 Month Performance-17.27%-8.58%-9.55%-7.70%1 Year Performance-57.76%-20.52%11.83%1.49% Bone Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBLGBone Biologics0.2473 of 5 stars$0.68+1.4%N/A-60.2%$2.22MN/A0.002Gap DownBSGMBioSig Technologies1.4011 of 5 stars$0.53+2.9%$2.75+418.9%-59.2%$9.14M$39,000.000.0050NURONeuroMetrix1.0596 of 5 stars$4.38-0.7%N/A+1.7%$9.02M$3.03M-0.9520Short Interest ↓INBSIntelligent Bio Solutions0.1178 of 5 stars$1.32-2.2%N/A-56.6%$8.96M$3.03M0.0010Short Interest ↑Negative NewsDHAIDIH Holding US0.5363 of 5 stars$0.18-0.8%N/A-88.4%$8.52M$64.47M-0.60N/AGap DownHigh Trading VolumeBLACBellevue Life Sciences AcquisitionN/A$1.95-21.1%N/A-87.6%$7.88MN/A0.00N/ANews CoverageHigh Trading VolumeBTCYBiotricityN/A$0.31-12.1%N/A-68.9%$7.66M$12.06M-0.2840IINNInspira Technologies Oxy B.H.N.1.2198 of 5 stars$0.60+1.3%N/A-67.4%$7.55MN/A0.0020Short Interest ↓News CoverageGap DownLYRALyra Therapeutics1.7693 of 5 stars$0.11-7.2%$1.25+1,017.1%-98.3%$7.37M$1.53M-0.0850Negative NewsMHUAMeihua International Medical Technologies1.7467 of 5 stars$0.29-6.9%N/A-51.7%$7.27M$94.25M0.00620Short Interest ↓Gap DownTNONTenon Medical1.4529 of 5 stars$1.16-3.3%$5.50+374.1%+52.8%$6.48M$3.28M-0.048 Related Companies and Tools Related Companies BSGM Alternatives NURO Alternatives INBS Alternatives DHAI Alternatives BLAC Alternatives BTCY Alternatives IINN Alternatives LYRA Alternatives MHUA Alternatives TNON Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBLG) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bone Biologics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
